50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today CRIS ranks #11590 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$5.10 (0.39%)

Volume: 2M

Closed: Nov 26, 2021

Hollow Logo Score: -4.033

Curis Stock Forecast

$5.10 (0.39%)

Volume: 2M

Closed: Nov 26, 2021

Score Hollow Logo -4.033
Which way will CRIS go? Request
Key Stats
P/E Ratio -11.88
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] The Curis stock currently holds an RSI14 at 19 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Curis stock price ended on $5.10 on Friday after gaining 0.39%
(Updated on Nov 26, 2021)

Sell candidate since 2021-10-25 Loss -27.66%

The Curis stock price gained 0.39% on the last trading day (Friday, 26th Nov 2021), rising from $5.08 to $5.10. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 5.77% from a day low at $4.85 to a day high of $5.13. The price has fallen in 8 of the last 10 days and is down by -15.56% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 461 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $8.23 million.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.95 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -37.87% during the next 3 months and, with a 90% probability hold a price between $3.08 and $3.74 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 0.59%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Curis stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.16 and $6.47. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss

Curis finds support from accumulated volume at $5.08 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.28 between high and low, or 5.77%. For the last week, the stock has had a daily average volatility of 4.92%.

Curis is oversold on RSI14 (19). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Curis stock A Buy?

Curis holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.033

Predicted Opening Price for Curis of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$5.03 $5.10 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 13, 2021 "Raymond James" gave "$15.00" rating for CRIS. The price target was set to $7.54+0.4%.

Volatility and Risk
Daily Average Volatility: 4.92 %
Overall Risk: Very High High Medium Low Very Low
4.92 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $5.97
Price: $5.10
Support: $5.08

CRIS Insider Trading Show all Trades



Last 100 transactions
Buy: 26 853 736 | Sell: 722 901 (Shares)
Date Action Amount Person Type
Jan 28, 2021 Buy 180 000 Steinkrauss William Employee stock option (right to buy)
Jan 28, 2021 Buy 33 000 Rubin Marc Non Qualified Stock Option
Jan 28, 2021 Buy 126 000 Martell Robert Employee stock option (right to buy)
Jan 28, 2021 Buy 33 000 Kaitin Kenneth I Non Qualified Stock Option
Jan 28, 2021 Buy 330 000 Dentzer James E Employee stock option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 26 853 736 | Sell: 722 901 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 5.31 4.05 %
5.20 1.96 %
5.13 0.66 %
Current price: 5.10
Support 4.92 -3.54 %
4.85 -4.83 %
4.75 -6.93 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 6.28 23.14 %
6.01 17.84 %
5.97 17.06 %
Current price 5.10
Support 5.08 -0.39%
5.07 -0.59%
0 .

Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers. The company develops CUDC-907, an oral small molecule inhibitor of histone deacetylase and phosphatidylinositol-3-kinase enzymes, which is in Phase II clinical trials for advanced lymphomas and multiple myeloma. It also develops CUDC-427 that has completed Phase I clinical trials for advanced solid tumor and lympho... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE